NOVARTIS
With recent acquisitions topping $8.3 billion, drugmaker will take the lead in generics.
LEGISLATION
Most large, multistate class-action lawsuits will be shifted into federal courts.
CAGED CARBENE
Scientists trap a carbene inside a cage molecule, stabilizing it at room temperature.
PROTEIN BOOST
High-yield membrane protein production gets a push from a novel bacterial membrane protein.
ACQUISITION
Codexis buys Germany's Jülich Fine Chemicals, maker of enzymes and chiral intermediates.
PERCHLORATE
Safe daily dose for human ingestion accepted by EPA will guide cleanup of Superfund sites.
DYNAMITE ALGAE
Certain types of seaweed efficiently absorb TNT in contaminated coastal waters.
COX-2 INHIBITORS
FDA faces a tough decision over whether to allow Bextra, Celebrex, and Vioxx to remain on the market.
ENGINEERING PRIZES
Biochemist Leland Clark Jr. is honored for developing a variety of biosensors.
|
